| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.09 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.09 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.09 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.052 | 0.09 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.09 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |